Citius Oncology, Inc. ( CTOR) - Key Metrics
CTOR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | ? | ? | ? | ? |
| 2026Q1 | $0.05 | -$0.06 | -$0.08 | -$0.08 |
| 2025Q4 | ? | -$0.06 | -$0.07 | -$0.07 |
| 2025Q3 | ? | -$0.08 | ? | ? |
| 2025Q2 | ? | -$0.11 | ? | ? |
CTOR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | ? | ? |
| 2026Q1 | ? | -3.95 |
| 2025Q4 | ? | -8.22 |
| 2025Q3 | ? | -14.49 |
| 2025Q2 | ? | -2.15 |
CTOR
Price: $0.80
52 week price:
Earnings Per Share: -0.48 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 76.8 million